Publications by authors named "Yaswanthi Yanamadala"

Poor aqueous solubility and bioavailability limit the translation of new drug candidates into clinical applications. Nanocrystal formulations offer a promising approach for improving the dissolution rate and saturation solubility. These formulations are applicable for various routes of administration, with each presenting unique opportunities and challenges posed by the physiological barriers.

View Article and Find Full Text PDF

Following traumatic brain injury (TBI), secondary brain damage due to chronic inflammation is the most predominant cause of the delayed onset of mood and memory disorders. Currently no therapeutic approach is available to effectively mitigate secondary brain injury after TBI. One reason is the blood-brain barrier (BBB), which prevents the passage of most therapeutic agents into the brain.

View Article and Find Full Text PDF

Introduction: The impact that vitamin D (vit D) has on a variety of medical conditions like diabetes, cardiovascular, oncological, and central nervous system disorders has been a topic of interest for many years now. It is well-known that vit D deficiency is substantially more common in epileptics than in healthy subjects. The current research was piloted to analyse the vit D levels of the blood in newborns with seizures, as well as mothers' vit D status included subjects.

View Article and Find Full Text PDF

The blood-brain barrier (BBB) is an obstacle to the permeation of most therapeutic drugs into the brain, limiting treatments for neurological disorders. Drugs loaded within nanocarriers that pass through the BBB can overcome this limitation. Halloysite consists of naturally occurring biocompatible clay nanotubes of 50 nm diameter and 15 nm lumen, allowing the loading and sustained release of loaded drugs.

View Article and Find Full Text PDF

Imbalances in levels of glutamate (GLU) and gamma-aminobutyric acid (GABA) and their sub-second signaling dynamics occur in several brain disorders including traumatic brain injury, epilepsy, and Alzheimer's disease. The present work reports on the optimization and in vivo testing of a silicon (Si) multifunctional biosensor probe for sub-second simultaneous real-time detection of GLU and GABA. The Si probe features four surface-functionalized platinum ultramicroelectrodes (UMEs) for detection of GLU and GABA, a sentinel site, and integrated microfluidics for in-situ calibration.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Yaswanthi Yanamadala"

  • - Yaswanthi Yanamadala's research focuses on innovative therapeutic approaches to overcome the challenges presented by the blood-brain barrier (BBB), particularly in the treatment of traumatic brain injury (TBI) and neurological disorders.
  • - Recent studies demonstrate the efficacy of intranasal delivery methods for therapeutic agents, including cell-penetrating peptides and clay nanotubes, which enhance brain delivery, reduce inflammation, and improve neurological function post-TBI.
  • - Additionally, Yanamadala investigates the correlation between vitamin D levels in neonates and the incidence of seizures, as well as the development of multifunctional probes for real-time monitoring of neurotransmitters like glutamate and GABA, aiming to provide better diagnostic and therapeutic mechanisms for brain-related conditions.